Mapping MHC-Resident Transplantation Determinants

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 8, 2007, Pages 986-995

  Malkki, Mari ^a   Gooley, Ted A ^a   Horowitz, Mary M ^b   Absi, Lena ^c   Christiansen, Frank T ^d   Cornelissen, Jan J ^e   Dormoy, Anne ^c   Dubois, Valerie ^c   Gagne, Katia ^c   Gluckman, Eliane ^f   Haagenson, Michael D ^g   Oudshoorn, Machteld ^h   Spellman, Stephen ⁱ   Petersdorf, Effie W ^a,j  

^a Fred Hutchinson Cancer Research Center   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d ROYAL PERTH HOSPITAL   (Australia)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f SAINT LOUIS HOSPITAL   (France)

^g CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^h Europdonor Foundation   (Netherlands)

ⁱ NATIONAL MARROW DONOR PROGRAM   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Hematopoietic cell transplantation; MHC; Microsatellite

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER MORTALITY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC CODE; GENETIC VARIABILITY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; HUMAN CELL; LIVING DONOR; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROSATELLITE MARKER; MORBIDITY; MORTALITY; RISK ASSESSMENT;

FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 34447302894     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.05.007     Document Type: Article

References (54)

1. Sasazuki T., Juji T., Morishima Y., et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 339 (1998) 1177-1185
2. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104 (2004) 1923-1930
3. Petersdorf E.W., Anasetti C., Martin P.J., et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 104 (2004) 2976-2980
4. Shiina T., Inoko H., and Kulski J.K. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64 (2004) 631-649
5. The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 401 (1999) 921-923
6. Horton R., Wilming L., Rand V., et al. Gene map of the extended human MHC. Nat Rev Genet 5 (2004) 889-899
7. Gourraud P.A., Mano S., Barnetche T., Carrington M., Inoko H., and Cambon-Thomsen A. Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis. Tissue Antigens 64 (2004) 543-555
8. Carrington M., Marti D., Wade J., et al. Microsatellite markers in complex disease: mapping disease associated regions within the human Major Histocompatibility Complex. In: Goldstein D.B., and Schlötterer C. (Eds). Microsatellites: Evolution and Applications (1999), Oxford University Press, Oxford, England 225-237
9. Cullen M., Perfetto S.P., Klitz W., Nelson G., and Carrington M. High-resolution patterns of meiotic recombination across the human major histocompatibility complex. Am J Hum Genet 71 (2002) 759-776
10. Jeffreys A.J., Murray J., and Neumann R. High-resolution mapping of cross-overs in human sperm defines a minisatellite associated recombination hotspot. Mol Cell 2 (1998) 267-273
11. Malkki M., Single R., Carrington M., Thomson G., and Petersdorf E. MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies. Tissue Antigens 66 (2005) 114-124
12. Moghaddam P.H., Zwinderman A., Kazemi M., et al. D6STNFa microsatellite locus correlates with CTLp frequency in unrelated bone marrow donor-recipient pairs. Hum Immunol 59 (1998) 295-301
13. Witt C., Moghaddam P.H., van der Meer R., et al. Matching for TNF microsatellites is strongly associated with matching for other non-HLA MHC sequences in unrelated bone marrow donor-recipient pairs. Hum Immunol 60 (1999) 862-866
14. Li S., Kawata H., Katsuyama Y., et al. Association of polymorphic MHC microsatellites with GVHD survival and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci. Tissue Antigens 63 (2004) 362-368
15. Carrington M., and Wade J. Selection of transplant donors based on MHC microsatellite data. Hum Immunol 50 (1996) 151-154 6Erratum Hum Immunol. 1996;51:106-109
16. Foissac A., Fort M.L., Giraldo P., Abbal M., Raffoux C., and Cambon-Thomsen A. Microsatellites in the HLA region potential applications in bone marrow transplantation. Transplant Proc 29 (1997) 2374-2375
17. Foissac A., Fort M., Clayton J., et al. Microsatellites in the HLA region HLA prediction and strategies for bone marrow donor registries. Transplant Proc 33 (2001) 491-492
18. Petersdorf E.W., Gooley T.A., Anasetti C., et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92 (1998) 3515-3520
19. Petersdorf E.W., Gooley T., Malkki M., et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 112 (2001) 988-994
20. Hurley C.K., Fernandez-Vina M., Hildebrand W.H., et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol 68 (2007) 30-40
21. Mickelson E., Damodaran A., He P., et al. Standardization of microsatellite data: comparative analysis of results from 13th IHWS participating laboratories and establishment of a microsatellite reference panel and standard nomenclature. In: Hansen J.A. (Ed). Immunobiology of the Human MHC Vol. 1 (2007), IHWG Press, Seattle, WA 1277-1314 Proceedings of the 13th International Histocompatibility Workshop and Conference
22. Hartl D.L., and Clark A.G. Principles of Population Genetics. 3rd ed. (1997), Sinauer Associates, Sunderland, MA
23. Leal S.M. Detection of genotyping errors and pseudo-SNPs via deviations from Hardy-Weinberg Equilibrium. Genet Epidemiol 29 (2005) 204-214
24. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
25. Farag S.S., Bacigalupo A., Eapen M., et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant 12 (2006) 876-884
26. Hsu K.C., Gooley T., Malkki M., et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant 12 (2006) 828-836
27. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
28. Miretti M.M., Walsh E.C., Ke X., et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 76 (2005) 634-646
29. Mullighan C.G., and Bardy P.G. Directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 127-144
30. Middleton P.G., Taylor P.R., Jackson G., Proctor S.J., and Dickinson A.M. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 92 (1998) 3943-3948
31. Holler E., Rogler G., Brenmoehl J., et al. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 107 (2006) 4189-4193
32. Lin M.T., Storer B., Martin P.J., et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 349 (2003) 2201-2210
33. Mullighan C., Heatley S., Doherty K., et al. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation 77 (2004) 587-596
34. Rocha V., Franco R.F., Porcher R., et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 100 (2002) 3908-3918
35. Socie G., Loiseau P., Tamouza R., et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 72 (2001) 699-706
36. Takahashi H., Furukawa T., Hashimoto S., et al. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 26 (2000) 1317-1323
37. Ishikawa Y., Kashiwase K., Akaza T., et al. Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 29 (2002) 569-575
38. Keen L.J., Defor T.E., Bidwell J.L., et al. Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood 103 (2004) 3599-3602
39. Bogunia-Kubik K., Polak M., and Lange A. TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 32 (2003) 617-622
40. Kikuchi K., Naruse T.K., Onizuka M., et al. Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers in chromosome 22. Immunogenetics 59 (2007) 99-108
41. Loiseau P., Esperou H., Busson M., et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation. Bone Marrow Transplant 30 (2002) 497-502
42. Shaw B.E., Marsh S.G., Mayor N.P., Russell N.H., and Madrigal J.A. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 7 (2005) 1220-1226
43. Shaw B.E., Potter M.N., Mayor N.P., et al. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplant 31 (2003) 1001-1008
44. Fleischhauer K., Locatelli F., Zecca M., et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with non-permissive HLA-DPB1 disparity in host-versus-graft direction. Blood 107 (2006) 2984-2992
45. Klitz W., Maiers M., Spellman S., et al. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62 (2003) 296-307
46. Knipper A.J., Hakenberg P., Enczmann J., et al. HLA-DRB1,3,4,5 and -DQB1 allele frequencies and HLA-DR/DQ linkage disequilibrium of 231 German caucasoid patients and their corresponding 821 potential unrelated stem cell transplants. Hum Immunol 61 (2000) 605-614
47. Begovich A.B., Moonsamy P.V., Mack S.J., et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens 57 (2001) 424-439 6Erratum: Tissue Antigens. 2001;58:431
48. Goulmy E., Schipper R., Pool J., et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334 (1996) 281-285
49. Tishkoff S.A., Pakstis A.J., Ruano G., and Kidd K.K. The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus. Am J Hum Genet 67 (2000) 518-522
50. Guo Z., Hood L., Malkki M., and Petersdorf E.W. Long-range multilocus haplotype phasing of the MHC. Proc Natl Acad Sci U S A 103 (2006) 6964-6969 6Erratum: Proc Natl Acad Sci U S A. 2006;103:9374
51. Collins R.W. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur J Immunogenet 31 (2004) 105-114
52. Kitcharoen K., Witt C.S., Romphruk A.V., Christiansen F.T., and Leelayuwat C. MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome. Hum Immunol 67 (2006) 238-246
53. Thorpe K.L., Abdulla S., Kaufman J., Trowsdale J., and Beck S. Phylogeny and structure of the RING3 gene. Immunogenetics 44 (1996) 391-396
54. Dorak M.T., Burnett A.K., and Worwood M. Hemochromatosis gene in leukemia and lymphoma. Leuk Lymphoma 43 (2002) 467-477